R Squared LTD Pds Biotechnology Corp Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Pds Biotechnology Corp stock. As of the latest transaction made, R Squared LTD holds 300 shares of PDSB stock, worth $504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$504% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.06MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.56 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$818,1040.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$697,3890.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$393,4710.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$225,5560.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $47.8M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...